Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.71 USD | +2.00% | +20.32% | +5.54% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 655M |
---|---|---|---|---|---|
Net income 2024 * | -123M | Net income 2025 * | -148M | EV / Sales 2024 * | - |
Net cash position 2024 * | 267M | Net cash position 2025 * | 153M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.32
x | P/E ratio 2025 * |
-4.91
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.48% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 day | +2.00% | ||
1 week | +20.32% | ||
Current month | +9.97% | ||
1 month | -14.75% | ||
3 months | -13.54% | ||
6 months | +37.15% | ||
Current year | +5.54% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 18-05-06 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Director of Finance/CFO | 50 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 21-11-08 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.48% | 4 M€ | -5.15% | - | |
0.03% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 9.71 | +2.00% | 277,184 |
24-05-02 | 9.52 | +2.04% | 555,938 |
24-05-01 | 9.33 | +5.66% | 762,455 |
24-04-30 | 8.83 | +7.29% | 761,332 |
24-04-29 | 8.23 | +1.98% | 425,342 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.54% | 655M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- ORIC Stock